Introduction & Hook
- Markets finished essentially flat today as oil’s dramatic 11.5% plunge collided with escalating Iran tensions, creating a tug-of-war that left the S&P 500 down just 0.2% at current levels while crude crashed to $83.85
- The defining story: geopolitical relief rallies are getting harder to sustain as reports of Iranian naval mines in the Strait of Hormuz reminded traders that this crisis is far from over
Today’s Scorecard — What Worked & What Didn’t
- Vertex Pharmaceuticals (VRTX) led the charge, soaring 8.3% to $499.17 on stellar kidney drug trial results, while semiconductors managed a modest 0.7% gain despite afternoon pressure
- Communication services (+0.3%) found support from Meta (+1.03%) and Alphabet (+0.30%), showing resilience amid broader weakness
- Energy sector (-1.3%) and healthcare (-0.7%) were the day’s biggest losers, with Centene (CNC) plummeting on worse-than-expected ACA membership projections
- Market breadth remained bearish with only 40% of stocks above their 20-day moving average and the 4% sentiment reading still neutral at best
Key Earnings & Economic Calendar
- Oracle (ORCL) retreated 1.37% to $149.49 ahead of its after-hours earnings release, while software names broadly sold off with the iShares Software ETF dropping 2.3%
- Several biotech names reported mixed results in the SIP feed, with ADC Therapeutics (ADCT) gaining on better Q4 results while Esperion (ESPR) disappointed
- Tomorrow brings no major economic releases, keeping focus on geopolitical developments and any overnight Iran news
- After-hours earnings tonight include Oracle results, which could set the tone for tech tomorrow given software sector weakness
Tomorrow’s Watchlist & Setups
- VRTX at $499 — momentum breakout on kidney drug catalyst, watch for continuation above $500 psychological level with strong volume
- AAOI at $120.48 — telecom stock showing 8.9% gains and appearing in Darvas Box signals, key resistance near $125
- NCI at $12.00 — apparel name with explosive 15% move appearing in multiple momentum scans, consolidation setup if it holds $11.50
- UCO at $34.25 — leveraged oil ETF showing reversal signals despite energy weakness, bounce play if crude finds support at $83
- Focus on healthcare momentum plays following VRTX success, particularly biotech names with upcoming catalysts
Strategy Outlook & Scenarios
- Bullish scenario: Iran tensions genuinely de-escalate with concrete diplomatic progress, sending oil lower and growth stocks higher with SPY reclaiming 4180 resistance
- Bearish scenario: Naval mine reports prove accurate or shipping disruptions escalate, triggering another energy spike and broad market selloff below 4120 support
- Momentum signals remain mixed with 2LYNCH showing 48 continuation signals but Reversal Bullish jumping to 115 names, suggesting increased volatility ahead
- CRT (Controlled Risk Taking) most relevant here — geopolitical uncertainty demands smaller position sizes and tight stops on any new entries
Summary & Final Thoughts
- Tomorrow’s game plan: Stay selective with individual stock momentum plays while avoiding broad market directional bets until Iran situation clarifies
- Key risk to manage is overnight geopolitical developments that could gap markets significantly in either direction
- Market stance remains defensive with selective opportunities in individual momentum names breaking out on company-specific catalysts